Dilated cardiomyopathy (DCM) is a type of heart disease characterized by poor pumping function. DCM is the most common cause of heart failure and is also the leading reason for heart transplantation. Many causes of DCM are unknown and the disease may be mild to severe. Optimization of the drug regimen for DCM may take months to years, with some patient refractory to treatment, resulting in progressive heart failure, heart transplantation, or death. Since the drug regimen for DCM treatment frequently varies from patient to patient, the current lack of a model system in the dish prevents accurate validation of treatment plans and prediction of drug side- effects. Current validation of long-term treatment in the laboratory employs traditional electrophysiology, both a time-consuming and destructive method for interrogating heart cell electrical activity. In order to trac the efficacy of applied drugs and detect potential long-term side-effects, what is needed is an engineered heart muscle (EHM) system that recapitulates the salient disease features of DCM and whose function can be both controlled and monitored acutely and chronically, precisely and non- destructively. To create this system, the candidate proposes (1) to create and characterize stem cell- derived heart cells that can be controlled and monitored with light, a technology called optogenetics; (2) to create and characterize optogenetic DCM-EHM made from these modified heart cells; and (3) to use optogenetic DCM-EHM to screen drugs that best mitigate the deleterious features of the disease. The candidate has a significant track record of research in optogenetics, stem cell biology, tissue engineering, and cardiovascular disease, and will expand his technical skills and career development activities by closely interacting with his faculty mentor, advisory committee, and collaborators in those areas. At the end of the K01 award, the candidate's goal is to successfully obtain R01 funding. Together, with full institutional support i a rich institutional environment, the mentor, advisory committee, and collaborators are fully committed to facilitating his successful transition to an independent investigator.

Public Health Relevance

Dilated cardiomyopathy (DCM) is a heart disease characterized by an enlarged heart and poor pumping function and is the leading reason for heat failure and heart transplantation. The goal of this project is to study DCM in a dish with a human stem cell-based engineered heart muscle system whose function can be both controlled and monitored very precisely with light. Results from this work will potentially lead to new strategies to lower morbidity and mortality, improve quality of life, optimize medical treatment, and reduce health care costs for patients with DCM, which will have a far reaching impact on public health.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Scientist Development Award - Research & Training (K01)
Project #
5K01HL130608-03
Application #
9543872
Study Section
Special Emphasis Panel (ZHL1)
Program Officer
Wang, Wayne C
Project Start
2016-02-01
Project End
2021-01-31
Budget Start
2018-02-01
Budget End
2019-01-31
Support Year
3
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Stanford University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
009214214
City
Stanford
State
CA
Country
United States
Zip Code
94304
Huang, Ngan F; Serpooshan, Vahid; Morris, Viola B et al. (2018) Big bottlenecks in cardiovascular tissue engineering. Commun Biol 1:199
Abilez, Oscar J; Tzatzalos, Evangeline; Yang, Huaxiao et al. (2018) Passive Stretch Induces Structural and Functional Maturation of Engineered Heart Muscle as Predicted by Computational Modeling. Stem Cells 36:265-277
Cordeiro, Christine; Abilez, Oscar J; Goetz, Georges et al. (2017) Optophysiology of cardiomyocytes: characterizing cellular motion with quantitative phase imaging. Biomed Opt Express 8:4652-4662
Wanjare, Maureen; Hou, Luqia; Nakayama, Karina H et al. (2017) Anisotropic microfibrous scaffolds enhance the organization and function of cardiomyocytes derived from induced pluripotent stem cells. Biomater Sci 5:1567-1578
Chuang, Wenpo; Sharma, Arun; Shukla, Praveen et al. (2017) Partial Reprogramming of Pluripotent Stem Cell-Derived Cardiomyocytes into Neurons. Sci Rep 7:44840
Kodo, Kazuki; Ong, Sang-Ging; Jahanbani, Fereshteh et al. (2016) iPSC-derived cardiomyocytes reveal abnormal TGF-? signalling in left ventricular non-compaction cardiomyopathy. Nat Cell Biol 18:1031-42